{
    "clinical_study": {
        "@rank": "55287", 
        "arm_group": [
            {
                "arm_group_label": "Tomosynthesis first", 
                "arm_group_type": "Active Comparator", 
                "description": "Tomosynthesis is done first"
            }, 
            {
                "arm_group_label": "CT first", 
                "arm_group_type": "Active Comparator", 
                "description": "CT is done first"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the imaging performance of an investigational breast\n      computed tomography (CT) scanner, built at UC Davis, with that of an FDA-Approved breast\n      tomosynthesis scanner (capable of producing standard 2-D mammography and 3-D tomosynthesis\n      images), built by Hologic, Incorporated, in a group of patients with suspected breast\n      cancer."
        }, 
        "brief_title": "Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The primary aim of this study is the comparison of tumor conspicuity on images taken by both\n      systems (computed tomography versus standard 2-D mammography versus 3-D tomosynthesis) using\n      a ten point conspicuity scale as the end-point. Secondary aims will be to compare the number\n      of lesions detected by the two systems, and to compare the estimated radiation dose of the\n      two systems."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  35 years of age or older\n\n          -  While male patients will not be explicitly excluded, it is expected that all patients\n             in this study will be women\n\n          -  Diagnostic findings from prior mammography suspicious for, or highly suggestive of,\n             breast malignancy -BIRADS (Breast Imaging Reporting and Data System) categories 4 and\n             5\n\n          -  Scheduled for ultrasound or stereotactic core biopsy\n\n          -  Ability to lie still on a table top for up to 10 minutes, longer than the typical\n             breast CT duration.\n\n          -  Ability to understand risks, procedures, and benefits involved\n\n        Exclusion Criteria:\n\n          -  Recent breast biopsy\n\n          -  History of breast augmentation implant\n\n          -  Pregnant or Positive urine pregnancy test (UPT) or currently breast-feeding\n\n          -  History of moderate or severe adverse reaction to iodinated contrast injection\n\n          -  Recent serum creatinine \u2265 1.5 mg/dL\n\n          -  History of Diabetes Mellitus\n\n          -  Currently taking Glucophage or Glucovance (Metformin)\n\n          -  History of chronic asthma\n\n          -  History of allergy to iodine\n\n          -  Multiple food and/or drug allergy\n\n          -  Renal disease\n\n          -  History of pulmonary disease, phobia of breath holding, or other condition that could\n             prevent the subject from being able to perform the 16 second breath hold"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "112", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852032", 
            "org_study_id": "221183"
        }, 
        "intervention": {
            "arm_group_label": [
                "Tomosynthesis first", 
                "CT first"
            ], 
            "description": "Computed Tomography and Mammography and Tomosynthesis", 
            "intervention_name": "Computed Tomography and Mammography and Tomosynthesis", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Breast Cancer", 
        "lastchanged_date": "May 8, 2013", 
        "location": {
            "contact": {
                "email": "john.brock@ucdmc.ucdavis.edu", 
                "last_name": "John M Brock, BS", 
                "phone": "916-734-3101"
            }, 
            "facility": {
                "address": {
                    "city": "Sacramento", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "95817"
                }, 
                "name": "UC Davis Medical Center"
            }, 
            "investigator": {
                "last_name": "John M Boone, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis", 
        "overall_official": {
            "affiliation": "University of California, Davis", 
            "last_name": "John M Boone, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparison of tumor conspicuity using a 10 point conspicuity scale", 
            "measure": "Tumor conspicuity", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852032"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of California, Davis", 
            "investigator_full_name": "John M. Boone, PhD", 
            "investigator_title": "Study Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To compare the number of lesions detected by the two systems", 
                "measure": "Compare the number of lesions and Radiation dose", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "To compare the estimated radiation dose of the two systems.", 
                "measure": "Comparison of radiation doses", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "University of California, Davis", 
        "sponsors": {
            "collaborator": {
                "agency": "Hologic, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of California, Davis", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2010", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}